First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

527 Reviews

Credit Rating - XING LIN CHINESE MEDICINE LIMITED

ANALYSIS
Credit Risk Update: ACCOUNTS DUE FLAG: XING LIN CHINESE MEDICINE LIMITED, 75 CARRICKBLACKER ROAD, PORTADOWN, CRAIGAVON, ARMAGH, BT63 5BA. The legal status is a Private Limited Company and the current status at the registry of companies is Active - Proposal to Strike off. The last filed accounts are dated 26 November 2020. The company was incorporated on 28 November 2016.

The accounts next due date is 31 August 2022. There are no mortgages.

The above was based on public record information as at 8 November 2024 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: NI642388
Date Incorporated: 28 November 2016
Date Latest Accounts: 26 November 2020
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: None
Registered Number: NI642388
Annual Return: Unknown
Registered Office: 75 CARRICKBLACKER ROAD, PORTADOWN, CRAIGAVON, ARMAGH, BT63 5BA
SIC Code and Operations: 86900
SECURED CREDITORS
Number of Mortgages 0
Satisfied Mortgages 0
Part Satisfied Mortgages 0
Unsatisfied Mortgages 0
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

XING LIN CHINESE MEDICINE LIMITED

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 18 November 2024 Copyright © 2024 First Report Ltd


Recent Searches

Reg No. Reg Name Status
12522325 XING LONG 99 LTD Active
11488967 XING LONG ASSET MANAGEMENT LTD Dissolved
14885171 XING LONG CHEUNGS TAKEAWAY LTD Active
07564219 XING LONG GE LTD Active
06361464 XING LONG LTD Dissolved

In using this service you agree to the Terms and Conditions

© 2024 First Report Ltd